Literature DB >> 15846390

Chorioamnionitis is associated with placental transmission of human immunodeficiency virus-1 subtype E in the early gestational period.

Lertlakana Bhoopat1, Surapan Khunamornpong, Pannee Sirivatanapa, Tat Rithaporn, Piyaporn Lerdsrimongkol, Paul S Thorner, Tanin Bhoopat.   

Abstract

The frequency and the cellular basis for HIV-1 transmission from mother to child in the early gestational period are poorly understood. We compared the placentas of 24 women seropositive for HIV-1 subtype E and who had not received any antiretroviral drugs, to placentas of 25 seronegative women. All placentas were obtained during therapeutic abortion at 6-23 weeks gestation. Placentas and fetal organs were examined by routine light microscopy, immunostaining for p24 capsid protein, and in situ PCR to localize which cells were infected with HIV-1 subtype E. The number of previous abortions was not a factor in placental HIV infection since this number was higher in seronegative women (P < 0.01). There were no significant differences between the placentas of the two groups with respect to presence of chorioamnionitis, villitis, villous stromal fibrosis, infarction, abnormal villous maturation, deciduitis or decidual necrosis. HIV-1 subtype E was detected in up to 83% of placentas, either by immunostaining or in situ PCR, in trophoblast, villous stromal cells, Hofbauer cells, decidual and decidual glandular epithelium. Fetal organs were positive for HIV in 30% (6/20) of cases. There was a significant association between transmission of HIV to the fetus and the histologic findings of chorioamnionitis, plasmacellular deciduitis and decidual cell necrosis. This is the first report showing an association of chorioamnionitis with early in utero transmission of HIV-1 subtype E. This may help explain the cases of in utero transmission that persist despite antiretroviral prophylaxis, given that therapy is started in the late gestational period.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15846390     DOI: 10.1038/modpathol.3800418

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  7 in total

Review 1.  Heterogeneous pathways of maternal-fetal transmission of human viruses (review).

Authors:  A Saleh Younes; Márta Csire; Beatrix Kapusinszky; Katalin Szomor; Mária Takács; György Berencsi
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

2.  Transplacental Transmission of Human Papillomavirus.

Authors:  Anca Florina Zgura; Elvira Bratila; Simona Vladareanu
Journal:  Maedica (Buchar)       Date:  2015-06

Review 3.  The role of HIV replicative fitness in perinatal transmission of HIV.

Authors:  Xue-Qing Chen; Chang Liu; Xiao-Hong Kong
Journal:  Virol Sin       Date:  2011-06-12       Impact factor: 4.327

Review 4.  Mother-to-child transmission (MTCT) of HIV and drugs of abuse in post-highly active antiretroviral therapy (HAART) era.

Authors:  Vishnudutt Purohit; Rao S Rapaka; David Shurtleff
Journal:  J Neuroimmune Pharmacol       Date:  2010-09-14       Impact factor: 4.147

5.  Vertical Transmission of Hepatitis C Virus: Variable Transmission Bottleneck and Evidence of Midgestation In Utero Infection.

Authors:  Sébastien Fauteux-Daniel; Ariane Larouche; Virginie Calderon; Jonathan Boulais; Chanel Béland; Doris G Ransy; Marc Boucher; Valérie Lamarre; Normand Lapointe; Isabelle Boucoiran; Armelle Le Campion; Hugo Soudeyns
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

6.  Chorioamnionitis in pregnancy: a comparative study of HIV-positive and HIV-negative parturients.

Authors:  Amaka N Ocheke; Patricia A Agaba; Godwin E Imade; Olugbenga A Silas; Olanrewaju I Ajetunmobi; Godwins Echejoh; Clement Ekere; Ayuba Sendht; James Bitrus; Emmanuel I Agaba; Atiene S Sagay
Journal:  Int J STD AIDS       Date:  2015-04-16       Impact factor: 1.359

7.  Placental Macrophage (Hofbauer Cell) Responses to Infection During Pregnancy: A Systematic Scoping Review.

Authors:  Georgia Fakonti; Paschalia Pantazi; Vladimir Bokun; Beth Holder
Journal:  Front Immunol       Date:  2022-02-11       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.